Suppr超能文献

接受改良根治术的淋巴结阴性乳腺癌患者的合适前哨淋巴结数量:一项基于人群的研究。

The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study.

作者信息

Chi Huiying, Zhang Chenyue, Wang Haiyong, Wang Zhehai

机构信息

Shanghai Geriatrics Institute of Traditional Chinese Medicine, Shanghai 200032, China.

Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

出版信息

Oncotarget. 2017 Aug 7;8(39):65668-65676. doi: 10.18632/oncotarget.20052. eCollection 2017 Sep 12.

Abstract

Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate patients with negative lymph nodes underwent MRM. The Cox proportional hazard analysis was used to determine the effect of number of ELNs on cancer specific survival (CSS). The results showed that the number of ELNs was not an independent prognostic factor on CSS ( = 0.940). Then the X-tile mode was used to determine the appropriate threshold for ELNs count. The results showed that 9 was the appropriate cut-off point. Next, the log-rank χ test was used to analyze the CSS based on different subgroup variables. The results showed that some subgroup variables including age < 50/ ≥ 50, grade I/III, AJCC T1/T2, ER positive/negative and PR positive/negative ,demonstrated significant CSS benefits among the patients with the number of ELNs ≤ 9 (all, < 0.05). However, three subgroup variables including grade II, AJCC T3 and AJCC T4, the patients with the number of ELNs ≤ 9 did not bring significant CSS benefits (all, > 0.1). In conclusion, our study demonstrated that the number of ELNs was not an independent prognostic factor on CSS, and 9 can be selected as the appropriate cut-off point of ELNs for patients with negative lymph nodes who underwent MRM.

摘要

在改良根治性乳房切除术(MRM)后,检查的淋巴结数量(ELNs)是否会给淋巴结阴性的患者带来生存益处尚不确定。在我们的研究中,我们使用2004年至2009年的监测、流行病学和最终结果(SEER)数据库,筛选出接受MRM且淋巴结阴性的合适患者。采用Cox比例风险分析来确定ELNs数量对癌症特异性生存(CSS)的影响。结果显示,ELNs数量不是CSS的独立预后因素( = 0.940)。然后使用X-tile模式来确定ELNs计数的合适阈值。结果显示9是合适的切点。接下来,使用对数秩χ检验基于不同亚组变量分析CSS。结果显示,在ELNs数量≤9的患者中,包括年龄<50岁/≥50岁、I级/III级、美国癌症联合委员会(AJCC)T1/T2、雌激素受体(ER)阳性/阴性和孕激素受体(PR)阳性/阴性等一些亚组变量显示出显著的CSS益处(均为,< 0.05)。然而,包括II级、AJCC T3和AJCC T4在内的三个亚组变量,ELNs数量≤9的患者并未带来显著的CSS益处(均为,> 0.1)。总之,我们的研究表明,ELNs数量不是CSS的独立预后因素,对于接受MRM的淋巴结阴性患者,9可被选为ELNs的合适切点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fc0/5630362/424c22adae4c/oncotarget-08-65668-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验